Nov 20, 2018   SOURCE: PR NewsWire

Innovative Smartphone-based Retinal Camera Outperforms Expensive Table-top System in Detecting Diabetic Retinopathy in a Two-year Study

BANGALORE, India, November 20, 2018 /PRNewswire/ --

Smartphones have revolutionized the world in countless ways by opening new possibilities beyond a phone. Healthcare industry is embracing this with a rigour like never before. Major drivers for this leap are their portability, relative affordability and ease of use. One of the high impact areas for such smartphone-based technologies is in mass screening to prevent blindness due to Diabetic Retinopathy (DR).

(Logo: https://mma.prnewswire.com/media/652990/Remidio_Logo.jpg )

(Photo: https://mma.prnewswire.com/media/786106/Remedio_Fundus_on_Phone.jpg )

A team of researchers from Aravind Eye Hospitals, led by Dr. Rengaraj Venkatesh and Dr. Sabyasachi Sengupta, scientifically assessed the use of smartphone-based screening for DR in a 2-year prospective study.

233 eyes were imaged using two devices - the Remidio Fundus-On-Phone (FOP), a smartphone-based portable fundus camera, and TOPCON TRC-50DX, a conventional desktop retinal-camera which then were compared to a standard clinical examination by an ophthalmologist for the detection of any type of DR. FOP scored over TRC-50DX in the areas of image quality, ease of use and patient comfort in the study. Images from FOP were found to be better than the images from the TRC-50DX desktop imaging system. 59-74% of images from FOP were deemed excellent compared to 52-61% on the TRC-50DX. Fewer number of images from FOP were deemed ungradable (1.7-2.1%) compared to the TRC-50DX (2.6-4.3%). This study has been published in the October issue of Ophthalmology Retina [https://www.ophthalmologyretina.org/article/S2468-6530(18)30288-4/abstract ].

This exciting result is thus set to rewrite the existing protocols in diabetic retinopathy screening. It is particularly re-assuring to 400 million patients with diabetes worldwide who are at the risk of losing vision due to DR, if not detected early.

Remidio Innovative Solutions [http://remidio.com/vision ], is an Indian technology start-up that has developed patented technologies to transform a standard smartphone camera into a high quality and portable retinal camera providing point of care screening for DR, while taking the output a notch higher. Earlier this year, an automated artificial intelligence algorithm was integrated on the Remidio FOP for the first time in the world - delivering 99.1% sensitivity in detecting Sight threatening Diabetic Retinopathy. That study was published in Nature EYE [https://www.nature.com/articles/s41433-018-0064-9 ].

About Remidio Innovative Solutions: 

Remidio seeks to impact preventable blindness by creating accessible technologies that are smart and simple to use. For more information, visit: http://remidio.com/vision. 

        

        Media contact: 
        Alok Raj K 
        +91-735-353-9000 
        alokraj@remidio.com

 

. 


    Photo: 
    https://mma.prnewswire.com/media/786106/Remedio_Fundus_on_Phone.jpg



    https://mma.prnewswire.com/media/652990/Remidio_Logo.jpg

SOURCE Remidio Innovative Solutions Pvt Ltd